Nu-Med Plus, Inc. (NUMD)

USD 0.09

(2.78%)

Market Cap (In USD)

7.1 Million

Revenue (In USD)

-

Net Income (In USD)

-125.52 Thousand

Avg. Volume

84.19 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0126-0.09
PE
8.5
EPS
0.01
Beta Value
0.851
ISIN
US67021R1041
CUSIP
67021R104
CIK
1543637
Shares
83548500.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. William R. Colvin
Employee Count
-
Website
https://www.nu-medplus.com
Ipo Date
2014-09-25
Details
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.

More Stocks